Skip to main content
. 2024 Aug 18;49:100844. doi: 10.1016/j.ctro.2024.100844

Table 1.

Clinical and pathological baseline characteristics. Data are shown as median (interquartile range) or absolute numbers (percentage). * Smoking defined as actively smoking or stopped smoking in the last 12 months. ** Tumor size as measured on mammography or MRI. *** Excision volume based on pathologic measurements.

IOERT, n = 241
EB-APBI, n = 164
p-value
n; median %; IQR n; median %; IQR
Age (years) 69 65–73 68 64–73 0.846
Body mass index (kg/m2)
< 25
≥ 25
Unknown

97
144
1

40
60
0

38
126
1

23
77
1
0.002
Diabetes mellitus
Yes
No

28
213

12
88

18
146

11
89
0.968
Smoking*
Yes
No

83
158

34
66

67
97

41
59
0.227
Tumor size** (mm) 12 9–16 11 8–17 0.862
Excision volume (mL)*** 104 63–154 98 63–138 0.592
Tumor location
Medial
Central/lateral

59
182

25
75

43
121

26
74
0.780
pT stage
Tis
T1
T2

13
204
24

5
85
10

22
118
24

13
72
15
0.004
pN stage
pN0
≥ pN1mi
Unknown

213
18
10

88
8
4

138
5
21

84
3
13
0.001
Grade
1
2
3
Unknown

75
98
49
19

31
41
20
8

49
67
23
25

30
41
14
15
0.069
Tumor subtype
Luminal
HER2+
Triple-negative
Unknown

200
12
13
16

83
5
5
7

120
9
6
29

73
6
4
18
0.006